Researcher develops ‘100x more effective’ solid tumor antibody therapy
A researcher at UVA medical school has developed a ‘two-headed’ antibody approach to treat ovarian cancer and solid tumors.
A researcher at UVA medical school has developed a ‘two-headed’ antibody approach to treat ovarian cancer and solid tumors.
A research team at VIB-UGent developed an immunotherapy treatment that destroyed tumors while stimulating the immune system in mice which may improve efficacy of checkpoint inhibitors.
The NHS has signed a commercial deal with Novartis, which will see ‘game changer’ therapy Kymriah supplied to children and young people in the UK.